/
Other
Age
48
Pipeline Programs↗
31
Active Trials↗
45
Companies Involved↗
Age is a moderately active landscape with 48 programs across 45 companies. The most active players are Sanofi, Ascentage Pharma Group Inc., Getz Pharma. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical30
Phase 210
Phase 35
Approved
No programs
Analysis
Modality Breakdown
91%
Small molecule
40 of 44 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 44 classified programs, each share of the total. Modality classified for 100% of 48 pipeline programs.
Analysis
Trial Status
283
clinical trials
Completed181 · 64%
Unknown status36 · 13%
Recruiting21 · 7%
Terminated17 · 6%
Withdrawn14 · 5%
Not yet recruiting5 · 2%
Other9 · 3%
Clinical Trials
Trial Activity
283 trials
Soaked Pharyngeal Packing Agents in Septoplasty
Recruiting·—·Phase 3·NCT07486544·90 enrolled
PET Image in PAH Patients
Recruiting·—·Phase 1·NCT05452889·71 enrolled
Colistin Dosage Prsonalization Approach
Recruiting·—·N/A·NCT06472271·100 enrolled
BMAC Loaded Collagen Jumping the Gap Around Immediate Implants
Recruiting·—·N/A·NCT05817526·20 enrolled
Page 1 of 19
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)